Back to search
FDAFDA · Food and drugs·Recall number Z-1825-2023

Philips Tempus LS-Manual Defibrillator, Part Number: 00-3020

Published June 21, 2023 · Recall initiated: May 8, 2023

Summary

FDA records medical device Class II recall Z-1825-2023, published June 21, 2023 and initiated May 8, 2023. Recalling firm: Remote Diagnostic Technologies Ltd.; Status: Ongoing; Reported quantity: 1147; Lot: UDI-DI: 07613365002737. Serial numbers prior to 7022.001634. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defibrillator/pacemaker module (DPM) may encounter a problem causing communication from the Mainboard to the DPM to fail, leading to no or ineffective pacing with displayed error message "HW failure DPM".

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remote Diagnostic Technologies Ltd.
Distributor
US Nationwide distribution in the states of UT, CO, CA, NE, IL, TX, WV, KS, GA.
Lot
UDI-DI: 07613365002737. Serial numbers prior to 7022.001634
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Related recalls

Questions about this recall

Was Philips Tempus LS-Manual Defibrillator, Part Number: 00-3020 recalled?

Yes. FDA published recall Z-1825-2023 on June 21, 2023. Reported hazard: Defibrillator/pacemaker module (DPM) may encounter a problem causing communication from the Mainboard to the DPM to fail, leading to no or ineffective pacing with displayed error message "HW failure DPM".

What should I do if I have this product?

Voluntary: Firm initiated · Letter